Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis

被引:42
作者
Keiding, S
Vilstrup, H
机构
[1] Aarhus Univ Hosp, Dept Med 5, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus, Denmark
关键词
esophageal varices; haematemesis; liver vein catheterization; portal hypertension;
D O I
10.1080/003655202760230946
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The hepatic venous pressure gradient (HVPG) is used to evaluate portal hypertension. Methods: We measured HVPG in two separate liver veins in 169 liver vein catheterizations in 102 cirrhosis patients and in 27 patients with no liver disease (controls). Results: In the controls, the two measurements differed by 0.0 +/- 1.8 mmHg (mean +/- s, n = 27), upper 95% confidence limit 3.6 mmHg (mean + 2 s). HVPG ranged from -0.1 to 8.3 mmHg, upper 95% confidence limit 6.7 mmHg. In cirrhosis, the two measurements agreed within +/-3.6 mmHg in 39%. In 61%, the measurements differed by 4-34 mmHg. In 35%, fluoroscopy demonstrated hepatic vein-to-hepatic-vein shunting in veins with low HVPG values. In some patients with HVPG measurements above 30 mmHg, Doppler ultrasound examination showed arterialization of the hepatic vasculature. Discussion: Our results demonstrate a hitherto unrecognized notable heterogeneity of the intrahepatic vasculature and HVPG measurements in cirrhosis. The presumption of interposition of non-flowing blood between the catheter tip and the portal system for the measurement of HVPG may thus be violated in about one-third of the cirrhosis cases because of abnormal outlet into hepatic venous shunts and in a minor fraction because of abnormal arterial inlet. In 26%, one measurement was below 12 mmHg, the other measurement above. If the HVPG had been measured in only one liver vein, 13% of the cases would have been classified in a lower risk group than appropriate according to the 12 mmHg concept of risk of bleeding from oesophageal varices.
引用
收藏
页码:960 / 964
页数:5
相关论文
共 18 条
[1]  
BRADLEY SE, 1950, CLIN ASPECTS HEPATIC, P71
[2]   Regulation of sinusoidal perfusion: In vivo methodology and control by endothelins [J].
Clemens, MG ;
Zhang, JX .
SEMINARS IN LIVER DISEASE, 1999, 19 (04) :383-396
[3]   RELATION BETWEEN PORTAL PRESSURE RESPONSE TO PHARMACOTHERAPY AND RISK OF RECURRENT VARICEAL HEMORRHAGE IN PATIENTS WITH CIRRHOSIS [J].
FEU, F ;
GARCIAPAGAN, JC ;
BOSCH, J ;
LUCA, A ;
TERES, J ;
ESCORSELL, A ;
RODES, J .
LANCET, 1995, 346 (8982) :1056-1059
[4]   PORTAL PRESSURE, PRESENCE OF GASTROESOPHAGEAL VARICES AND VARICEAL BLEEDING [J].
GARCIATSAO, G ;
GROSZMANN, RJ ;
FISHER, RL ;
CONN, HO ;
ATTERBURY, CE ;
GLICKMAN, M .
HEPATOLOGY, 1985, 5 (03) :419-424
[5]   HEMODYNAMIC EVENTS IN A PROSPECTIVE RANDOMIZED TRIAL OF PROPRANOLOL VERSUS PLACEBO IN THE PREVENTION OF A 1ST VARICEAL HEMORRHAGE [J].
GROSZMANN, RJ ;
BOSCH, J ;
GRACE, ND ;
CONN, HO ;
GARCIATSAO, G ;
NAVASA, M ;
ALBERTS, J ;
RODES, J ;
FISCHER, R ;
BERMANN, M ;
ROFE, S ;
PATRICK, M ;
LERNER, E .
GASTROENTEROLOGY, 1990, 99 (05) :1401-1407
[6]   REPRODUCIBILITY OF LIVER-BIOPSY DIAGNOSIS IN RELATION TO THE SIZE OF THE SPECIMEN [J].
HOLUND, B ;
POULSEN, H ;
SCHLICHTING, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1980, 15 (03) :329-335
[7]   ETHANOL ELIMINATION KINETICS IN HUMAN-LIVER AND PIG-LIVER INVIVO [J].
KEIDING, S ;
JOHANSEN, S ;
MIDTBOLL, I ;
RABOL, A ;
CHRISTIANSEN, L .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 237 (04) :E316-E324
[8]   DRUG ADMINISTRATION TO LIVER PATIENTS - ASPECTS OF LIVER PATHOPHYSIOLOGY [J].
KEIDING, S .
SEMINARS IN LIVER DISEASE, 1995, 15 (03) :268-282
[9]  
MAHARAJ B, 1986, LANCET, V1, P523
[10]   The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis [J].
Merkel, C ;
Bolognesi, M ;
Sacerdoti, D ;
Bombonato, G ;
Bellini, B ;
Bighin, R ;
Gatta, A .
HEPATOLOGY, 2000, 32 (05) :930-934